Skip to main content

Peer Review reports

From: CDC6, a key replication licensing factor, is overexpressed and confers poor prognosis in diffuse large B-cell lymphoma

Original Submission
10 Sep 2022 Submitted Original manuscript
4 Oct 2022 Reviewed Reviewer Report
8 Dec 2022 Reviewed Reviewer Report
15 Apr 2023 Author responded Author comments - Yuan Li
Resubmission - Version 2
15 Apr 2023 Submitted Manuscript version 2
21 May 2023 Author responded Author comments - Yuan Li
Resubmission - Version 3
21 May 2023 Submitted Manuscript version 3
1 Jun 2023 Author responded Author comments - Yuan Li
Resubmission - Version 4
1 Jun 2023 Submitted Manuscript version 4
12 Jun 2023 Author responded Author comments - Yuan Li
Resubmission - Version 5
12 Jun 2023 Submitted Manuscript version 5
13 Jun 2023 Author responded Author comments - Yuan Li
Resubmission - Version 6
13 Jun 2023 Submitted Manuscript version 6
26 Jun 2023 Reviewed Reviewer Report
12 Jul 2023 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
17 Jul 2023 Editorially accepted
13 Oct 2023 Article published 10.1186/s12885-023-11186-6

You can find further information about peer review here.

Back to article page